Gilead Sciences

Sr Therapeutic Specialist, Oncology - Albuquerque

United States

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree in a related scientific field, such as Biology, Pharmacy, or Nursing, and have a minimum of 5 years of experience as a Therapeutic Specialist, preferably in oncology. Strong sales and business development skills are required, along with the ability to understand and present complex clinical information to healthcare professionals. Experience in hospital and large account sales, managing through complex reimbursement issues, is also necessary.

Responsibilities

As a Senior Therapeutic Specialist, Oncology, the role involves representing Gilead’s products and services to a defined customer base, generating and growing sales within a specific geographic area, including in-person representation and face-to-face meetings with healthcare practitioners. Responsibilities include developing a business plan to achieve sales targets, identifying patient pathways, promoting products to oncologists and staff, facilitating patient access to treatment, establishing strong customer relationships, partnering with various teams on cross-functional projects, and assisting in identifying and resolving issues. The role also requires delivering disease awareness information, clinical updates, and ensuring safe and appropriate drug administration, as well as participating in professional events to promote company products.

Skills

Oncology
Sales
Healthcare Practitioner Engagement
Disease Awareness
Clinical Updates
Customer Relationship Management

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Key Metrics

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI